Company: DMAC
Filing Date: 2025-02-24
Form Type: 8-K
Source: 0001437749-25-004891
Chunk: 3

Company: DiaMedica Therapeutics Inc.
Filing Date: 2025-02-24
Form: 8-K
Item: Item 7.01
Chunk 3
---
Item 7.01

Regulation FD Disclosure.

The Company announced the appointment of Daniel J. O’ Connor as a director in a press release issued on February 24, 2025, which is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.

The information furnished under this Item 7.01 and Exhibit 99.1 to this Current Report on Form 8-K shall not be deemed “filed” for the purposes of Section 18 of the United States Securities Exchange Act of 1934, as amended (the “ Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be deemed incorporated by reference into any other filing by the Company under the Exchange Act or the United States Securities Act of 1933, as amended, except as otherwise expressly stated in such filing.

Item 9.01Financial Statements and Exhibits.